|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-8-13
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Rates of smoking in East Asian men range from >35% to >60%, and are increasing in women and the young.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0149-2918
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1027-39
|
|
pubmed:meshHeading |
pubmed-meshheading:17692719-Adult,
pubmed-meshheading:17692719-Aged,
pubmed-meshheading:17692719-Asian Continental Ancestry Group,
pubmed-meshheading:17692719-Benzazepines,
pubmed-meshheading:17692719-Double-Blind Method,
pubmed-meshheading:17692719-Female,
pubmed-meshheading:17692719-Follow-Up Studies,
pubmed-meshheading:17692719-Humans,
pubmed-meshheading:17692719-Korea,
pubmed-meshheading:17692719-Male,
pubmed-meshheading:17692719-Middle Aged,
pubmed-meshheading:17692719-Nicotinic Agonists,
pubmed-meshheading:17692719-Odds Ratio,
pubmed-meshheading:17692719-Quinoxalines,
pubmed-meshheading:17692719-Receptors, Nicotinic,
pubmed-meshheading:17692719-Smoking Cessation,
pubmed-meshheading:17692719-Taiwan,
pubmed-meshheading:17692719-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers.
|
|
pubmed:affiliation |
Department of Community Medicine, Buddhist Tzu Chi General Hospital and Tzu Chi University College of Medicine, Hualien, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
